Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma
Tim Underwood(Southampton General Hospital), Gareth J. Thomas(University of Southampton)
Cited by 182
Related Papers
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|The Lancet. Gastroenterology & hepatology|2019|64
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
|Cancer Research|2022|31